Evidence map›Paper›PMID 26147090›Full record

ReviewSmall GTPases2015

A role for the small GTPase Rac1 in vaccinia actin-based motility.

Diego E Alvarez, Hervé Agaisse

Abstract readReview
In one paragraph

Review in Small GTPases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. The role of actin cytoskeleton component Arp2/3 in inflammatory response.Frontiers in cell and developmental biology · 2025
    Review
  2. Article
  3. Article
  4. UpregulatedMolecular therapy oncolytics · 2020
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Diego E Alvareza Instituto de Investigaciones Biotecnológicas Dr. Rodolfo A. Ugalde; Universidad Nacional de San Martín-CONICET ; San Martín , Buenos Aires , Argentina.
Hervé Agaisse

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccinia virus dissemination relies on the recruitment of the nucleation promoting factor N-WASP underneath cell-associated extracellular virus (CEVs) and subsequent recruitment and activation of the ARP2/3 complex, a major actin nucleator of the host cell. We have recently discovered that, in addition to the N-WASP/ARP2/3 pathway, vaccinia actin-based motility also relies on the small GTPase Rac1 and its downstream effector the formin-type actin nucleator FHOD1. Here we discuss the potential signaling mechanisms supporting the integration of the N-WASP/ARP2/3 and Rac1/FHOD1 pathways. We suggest the existence of a receptor tyrosine kinase family member that would integrate the Src-dependent activation of the N-WASP/ARP2/3 pathway and the GTP exchange factor-dependent activation of the Rac1/FHOD1 pathway.

Indexed as

Virus ReleaseActin-Related Protein 2-3 ComplexActinsAnimalsHumansrac1 GTP-Binding ProteinVacciniaVaccinia virusViral ProteinsWiskott-Aldrich Syndrome Protein, NeuronalActin-Related Protein 2-3 ComplexActinsrac1 GTP-Binding ProteinViral ProteinsWiskott-Aldrich Syndrome Protein, Neuronalactin-based motilityARP2/3 complexDisseminationFHOD1N-WASPRac1spread from cell to cellvaccinia

Identifiers

PMID26147090
PMCPMC4601316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.